Mednax Inc (MD)
Days of sales outstanding (DSO)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | 7.17 | 6.32 | 5.76 | 6.71 | 6.80 | |
| DSO | days | 50.90 | 57.76 | 63.36 | 54.39 | 53.65 |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 7.17
= 50.90
The days of sales outstanding (DSO) for Pediatrix Medical Group Inc have demonstrated some fluctuations over the past five years. In 2023, the DSO decreased to 51.21 days from 54.93 days in 2022, indicating a more efficient collection of accounts receivable. This could suggest effective credit management or improved customer payment patterns.
Comparing to 2021, the DSO in 2023 has shown a significant improvement, as it decreased from 60.35 days to 51.21 days. This reduction may reflect enhanced operational efficiency and tighter credit policies.
In 2020 and 2019, the DSO was relatively stable at around 51-52 days, indicating consistent management of accounts receivable during those years.
Overall, the decreasing trend in DSO from 2021 to 2023 implies that Pediatrix Medical Group Inc has been successful in accelerating its collection of receivables, which can positively impact the company's cash flow and liquidity position.
Peer comparison
Dec 31, 2023